TLGY Acquisition said the underwriters of its IPO fully exercised their option to purchase an additional 3 million units at $10 each, resulting in additional gross proceeds of $30 million. The total number of units sold by the SPAC in the offering increased to 23 million units for aggregate gross proceeds of $230 million.
Units list on the Nasdaq under ticker symbol TLGYU.
TLGY intends to focus on the global biopharma or technology enabled B2C industries. Read more.
